Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

January 2025; Volume 45,Issue 1

Reviews

  • Open Access
    Ovarian Adult Granulosa Cell Tumors: A Scoping Review of DNA Alterations and Their Known Significance
    SVEN KARSTENSEN, KARSTEN KAISER, TIM SVENSTRUP POULSEN, KIRSTEN JOCHUMSEN, CLAUS HØGDALL, NIELS MARCUSSEN, FINN FRIIS LAUZSUS and ESTRID HØGDALL
    Anticancer Research January 2025, 45 (1) 1-10; DOI: https://doi.org/10.21873/anticanres.17388
  • Open Access
    Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy Resistance
    MELANIJA TALIJANOVIC, JOANNA LOPACINSKA-JØRGENSEN and ESTRID V. HØGDALL
    Anticancer Research January 2025, 45 (1) 11-26; DOI: https://doi.org/10.21873/anticanres.17389
  • Open Access
    Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor – Meta-analyses and Systematic Review
    SINAN HADDAD, JULIUS JOHANNES WEISE, STEFAN WAGENPFEIL, THOMAS VOGT and JOERG REICHRATH
    Anticancer Research January 2025, 45 (1) 27-37; DOI: https://doi.org/10.21873/anticanres.17390

Experimental Studies

  • Open Access
    Eribulin Induction of Immunogenic Cell Death (ICD): Comparison With Other Cytotoxic Agents and Temporal Relationship of ICD Biomarkers
    MINGFA ZANG, JIA ZHENG, XIAOYU AN, BO LI, HUAJUN YANG, BRIAN ERICKSON, RYAN KUNZ and BRUCE A. LITTLEFIELD
    Anticancer Research January 2025, 45 (1) 39-53; DOI: https://doi.org/10.21873/anticanres.17391
  • Open Access
    Interaction of Vitamin D-BODIPY With Fat Cells and the Link to Obesity-associated Vitamin D Deficiency
    NAZLI UÇAR, JUDE T. DEENEY, R. TAYLOR PICKERING, TING-YU FAN, RALF LOO, PETER M. MUELLER and MICHAEL F. HOLICK
    Anticancer Research January 2025, 45 (1) 55-63; DOI: https://doi.org/10.21873/anticanres.17392
  • Open Access
    SLC7A11/xCT-mediated Cystine Uptake Regulates Intracellular Glutathione and Promotes Antioxidant Defense in Lymphatic Endothelial Cells
    SHIHO HASHIGUCHI, TOMOKO TANAKA, RYOSUKE MANO, SEIJI KONDO and SHOHTA KODAMA
    Anticancer Research January 2025, 45 (1) 65-71; DOI: https://doi.org/10.21873/anticanres.17393
  • Open Access
    Impact of Rhenium(I)-Diselenoether Compound on Cell Adhesion, Migration, Invasion Capacities, and MMP-2 Release in MDA-MB-231 Breast Cancer Cells
    PHILIPPE COLLERY, DIDIER DESMAELE, ADHIKESAVAN HARIKRISHNAN and VIJAY VEENA
    Anticancer Research January 2025, 45 (1) 73-79; DOI: https://doi.org/10.21873/anticanres.17394
  • Open Access
    Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck
    NATSUKI SUGIYAMA, SATOSHI YAMADA, YUKI NAKAMURA, KOTARO MORITA, KOTARO KANO, KOTARO ISHIDA, KAZUTAKA TAKEUCHI, JUN-YA KITA, SOSUKE SAHARA, KOSUKE SUGAWARA, KEN-ICHIRO NAGAI, SHIGERU MATSUDA, AKITOSHI HAYASHI, YUSEI MAKOSHI, DAIKI MOCHIZUKI, HIROSHI NAKANISHI, ATSUSHI IMAI, YOSHINORI TAKIZAWA, YUKI MISAWA and KIYOSHI MISAWA
    Anticancer Research January 2025, 45 (1) 81-95; DOI: https://doi.org/10.21873/anticanres.17395
  • Open Access
    Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research January 2025, 45 (1) 97-103; DOI: https://doi.org/10.21873/anticanres.17396
  • Open Access
    Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase Concentrations
    BYUNG MO KANG, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research January 2025, 45 (1) 105-111; DOI: https://doi.org/10.21873/anticanres.17397
  • You have access
    Kisspeptin Retards Tumor Growth of Lewis Lung Carcinoma Cells Through p38 MAPK-mediated Senescence
    JEONG YOON LEE, JEONG NAM KIM and SUNG-GOOK CHO
    Anticancer Research January 2025, 45 (1) 113-122; DOI: https://doi.org/10.21873/anticanres.17398
  • You have access
    Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in Gastric Cancer
    YUSUKE TSURUDA, TAKAAKI MASUDA, YOSHIKI HIRAKI, MIWA KITAGAWA, DAI SHIMIZU, QINGJIANG HU, SHUHEI ITO, HAJIME OTSU, YOSUKE KURODA, HIDETOSHI EGUCHI, TAKAO OHTSUKA, SHOJI NATSUGOE and KOSHI MIMORI
    Anticancer Research January 2025, 45 (1) 123-133; DOI: https://doi.org/10.21873/anticanres.17399
  • You have access
    Hederagenin Glycoside Isolated from the Pericarps of Akebia quinata Fruits Induces Apoptotic Cell Death in Breast Cancer Cells
    AKIRA SATO, SAKURA MASAKA, AOI AISAKA, IKUTO ISHIBASHI, AYANO YABUKI, HINA NEMOTO, MAKOTO OHIRA, MASANORI YAMAURA, KATSUHIKO SUZUKI, KEIICHI MATSUZAKI, TSUKASA MATSUMOTO and YASUSHI KAWASAKI
    Anticancer Research January 2025, 45 (1) 135-144; DOI: https://doi.org/10.21873/anticanres.17400
  • You have access
    Garlic (Allium sativum L.) Organosulfur Compounds Inhibit Breast Cancer Cell Proliferation by Decreasing Steroid Sulfatase Levels
    AKIRA SATO, AYANO YABUKI, GENTA SATO, HINA NEMOTO, YUTA OGAWA and MAKOTO OHIRA
    Anticancer Research January 2025, 45 (1) 145-152; DOI: https://doi.org/10.21873/anticanres.17401
  • Open Access
    SLC15A2 Serves as a Novel Prognostic Biomarker and Target for Prostate Cancer
    WENJUN YIN, PINGKAIQI HE, ZHIHAO ZOU, JUNDONG LIN, ZHENGUO LIANG, ZHENJIE WU, JIANHENG YE, JIANMING LU and WEIDE ZHONG
    Anticancer Research January 2025, 45 (1) 153-172; DOI: https://doi.org/10.21873/anticanres.17402
  • Open Access
    Circular RNA hsa_circ_0004650 Enhances 5-Fluorouracil Resistance in Gastric Cancer via Sponging miR-145-5p
    FUSHENG ZHOU, JIALONG ZHUO, XUDONG XU, DUYI PAN, CHENWEN CAI, JIAXIN HUANG, XIANGUANG ZHAO, QIQI MAO, XIAOYUN JIANG, XU SUN, LIANG ZHONG, NAN GAO and JIAJIE CHEN
    Anticancer Research January 2025, 45 (1) 173-187; DOI: https://doi.org/10.21873/anticanres.17403

Clinical Studies

  • Open Access
    How to Predict Recurrence After Resection of Hepatocellular Carcinoma
    NATALIE PETRUCH, LOUISA BOLM, MARTINA NEBBIA, SHAHRZAD ARYA, MARCO VENTIN, MOTAZ QADAN, NAHEL ELIAS, JANNIS DUHN, DIRK RADES, LEIGH A. DAGEFORDE, KENNETH T. TANABE, JOSEPH FRANSES, VIKRAM DESHPANDE, ULRICH F. WELLNER, TOBIAS KECK, ONOFRIO CATALANO and CRISTINA R. FERRONE
    Anticancer Research January 2025, 45 (1) 189-199; DOI: https://doi.org/10.21873/anticanres.17404
  • You have access
    Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases
    CHRISTOS PANOTOPOULOS, GEORGE ATHANASIOU, STAVROS STAVROPOULOS, NICK BOUTOS, SHAILESH RAO, GEORGE PANAYOTOU, NEELAM K. VENKATARAMANA and GUNNAR RONQUIST
    Anticancer Research January 2025, 45 (1) 201-207; DOI: https://doi.org/10.21873/anticanres.17405
  • Open Access
    Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer
    KAZUTAKA DOI, MAKOTO SHINOTO, TETSURO ISOZAKI, TAKASHI IMAI, TOSHIKI AIBA, SUMITAKA HASEGAWA and TSUGUHIDE TAKESHIMA
    Anticancer Research January 2025, 45 (1) 209-217; DOI: https://doi.org/10.21873/anticanres.17406
  • Open Access
    Outcomes of Scapular Osteosarcoma
    LEILANI GARAYUA-CRUZ, SAMUEL E. BROIDA, STEVEN I. ROBINSON, SCOTT H. OKUNO, THANH P. HO, BRITTANY L. SIONTIS, COURTNEY E. SHERMAN, KRISTA A. GOULDING and MATTHEW T. HOUDEK
    Anticancer Research January 2025, 45 (1) 219-223; DOI: https://doi.org/10.21873/anticanres.17407
  • You have access
    Does Low-grade Follicular Lymphoma With a High Proliferation Index Require a Different Treatment Strategy? A Single Center Experience
    RAHIM A. JIWANI, EIRAJ KHAN, HASSAN ABDULAHI, URWAT VUSQA, CYRUS KHAN and YAZAN SAMHOURI
    Anticancer Research January 2025, 45 (1) 225-228; DOI: https://doi.org/10.21873/anticanres.17408
  • You have access
    The Challenge of Diagnosing Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
    SAHIL GARG, AMOL DUA, AMIR ANSARI and IMAD TABBARA
    Anticancer Research January 2025, 45 (1) 229-233; DOI: https://doi.org/10.21873/anticanres.17409
  • You have access
    Sun Exposure and Type 2 Diabetes Mellitus: A Prospective Follow-up Cohort Study from Southern Sweden
    PELLE G. LINDQVIST, ELISABETH EPSTEIN and MONA LANDIN-OLSSON
    Anticancer Research January 2025, 45 (1) 235-242; DOI: https://doi.org/10.21873/anticanres.17410
  • You have access
    Improved Vitamin D Status Is Associated With Lower Incidence of Stillbirth
    PELLE G. LINDQVIST and MIKA GISSLER
    Anticancer Research January 2025, 45 (1) 243-250; DOI: https://doi.org/10.21873/anticanres.17411
  • You have access
    Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma
    NOBUAKI ISHIHARA, SHOHEI KOMATSU, YOSHIHIKO YANO, YOSHIMI FUJISHIMA, JUN ISHIDA, MASAHIRO KIDO, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, TOSHIHIKO YOSHIDA, KENTARO TAI, KEISUKE ARAI, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, TAKANORI MATSUURA, TOSHIFUMI TADA, YUZO KODAMA and TAKUMI FUKUMOTO
    Anticancer Research January 2025, 45 (1) 251-260; DOI: https://doi.org/10.21873/anticanres.17412
  • You have access
    Preoperative High FIB-4 Index and NFS Scores Predict a Reduced Incidence of Metachronous Liver Metastasis Following Pancreaticoduodenectomy
    MAKOTO KAWAMOTO, YOSHIHIRO MIYASAKA, HIROKI KAIDA and MASATO WATANABE
    Anticancer Research January 2025, 45 (1) 261-266; DOI: https://doi.org/10.21873/anticanres.17413
  • Open Access
    Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting
    MAARET ESKELINEN, TUOMAS SELANDER, DENISE PEIXOTO GUIMARÃES, KAI KAARNIRANTA, KARI SYRJÄNEN and MATTI ESKELINEN
    Anticancer Research January 2025, 45 (1) 267-275; DOI: https://doi.org/10.21873/anticanres.17414
  • You have access
    Vascular Pain and Nurse Burden in Peripheral Administration of Fosaprepitant/Fosnetupitant: A Prospective Observational Study
    YUKO KUBOTA, SHIRO HATAKEYAMA, SHUHEI SUZUKI, HIROKI SAWADA, YUKO SATO, TAKASHI YOSHIOKA and CHIKA OZAWA
    Anticancer Research January 2025, 45 (1) 277-285; DOI: https://doi.org/10.21873/anticanres.17415
  • You have access
    Lipoprotein(a) as a Predictor of Nonalcoholic Fatty Liver After Pancreatectomy
    KYOHEI ABE, SHUICHI FUJIOKA, YUKI TAKANO, YOSHIHIRO SHIRAI, MASASHI TSUNEMATSU, MICHINORI MATSUMOTO, KENEI FURUKAWA, KOICHIRO HARUKI, SHINJI ONDA and TORU IKEGAMI
    Anticancer Research January 2025, 45 (1) 287-293; DOI: https://doi.org/10.21873/anticanres.17416
  • You have access
    Improvement in Survival in Patients With Advanced Non-small Cell Lung Cancer
    KEISHI YOSHIDA, KAORU WATANABE, TAKU NISHIMURA, HIROAKI IKUSHIMA, SAYAKA OHARA, HIDEYUKI TAKESHIMA, TOSHIO SAKATANI and KAZUHIRO USUI
    Anticancer Research January 2025, 45 (1) 295-305; DOI: https://doi.org/10.21873/anticanres.17417
  • You have access
    Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403)
    NAOTOSHI SUGIMOTO, JUNJI KAWADA, YOSHIO OKA, SHUGO UEDA, KOHEI MURAKAMI, KAZUHIRO NISHIKAWA, YUKINORI KUROKAWA, KAZUMASA FUJITANI, HISATO KAWAKAMI, SHUNJI ENDO, DAISUKE SAKAI, TOSHIO SHIMOKAWA and TAROH SATOH
    Anticancer Research January 2025, 45 (1) 307-313; DOI: https://doi.org/10.21873/anticanres.17418
  • You have access
    Tight Anastomosis of the Pancreatojejunostomy During Pancreatoduodenectomy May Cause Late Acute Pancreatitis
    MASASHI TSUNEMATSU, MITSURU YANAGAKI, RYOGA HAMURA, YOSHIHIRO SHIRAI, SHUNTA ISHIZAKI, SHINJI ONDA, MICHINORI MATSUMOTO, TOMOHIKO TANIAI, KOICHIRO HARUKI and TORU IKEGAMI
    Anticancer Research January 2025, 45 (1) 315-321; DOI: https://doi.org/10.21873/anticanres.17419
  • You have access
    Prognostic Relevance of Immunosuppressive CD155/TIGIT Signaling in Locally Advanced Rectal Cancer Patients With Neoadjuvant Chemoradiotherapy
    YUAN-YAO TSAI, TAO-WEI KE, CHI-HSIEN HUANG, TSUNG-WEI CHEN, YU-SEN LIN, TE-HONG CHEN, HUI-YU CHEN, WILLIAM TZU-LIANG CHEN, K. S. CLIFFORD CHAO and KEVIN CHIH-YANG HUANG
    Anticancer Research January 2025, 45 (1) 323-333; DOI: https://doi.org/10.21873/anticanres.17420
  • You have access
    EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?
    GIUSEPPINA IMPROTA, GIULIA VITA, ALFREDO TARTARONE, GIOVANNI CALICE, LUDMILA CARMEN OMER and ANGELA ZUPA
    Anticancer Research January 2025, 45 (1) 335-340; DOI: https://doi.org/10.21873/anticanres.17421
  • You have access
    Development of a Prognostic Model for Stage IV Colorectal Cancer Using Metastatic Patterns
    HIDETAKA KAWAMURA, TAKAHIRO IMAIZUMI, TEPPEI MIYAKAWA, EIICHI NAKAO, MASANORI KATAGATA, YUKITOSHI TODATE, YOSHINAO TAKANO, KOJI KONO and MICHITAKA HONDA
    Anticancer Research January 2025, 45 (1) 341-350; DOI: https://doi.org/10.21873/anticanres.17422
  • You have access
    Relationship Between 18F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma
    HIROMICHI OSHIRO, KOHEI MIZUTA, YUTA MIYASHI, YOSHIRO YOSHIKAWA, YASUNORI TOME and KOTARO NISHIDA
    Anticancer Research January 2025, 45 (1) 351-357; DOI: https://doi.org/10.21873/anticanres.17423
  • You have access
    Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer
    SO KASUGA, HIROAKI NOZAWA and SOICHIRO ISHIHARA
    Anticancer Research January 2025, 45 (1) 359-367; DOI: https://doi.org/10.21873/anticanres.17424
  • You have access
    Real-world Outcomes of Durvalumab Consolidation in Elderly Patients With Unresectable NSCLC Following CCRT With Daily Low-dose Carboplatin
    KEIJIRO YAMAUCHI, RIIKO KOMUTA, HIDETAKA TANABE, MASASHI YOKOYAMA, SO TAKATA, TAKAFUMI YANASE, YUKI HOSONO, SHINGO SATOH, NAOKO MORISHITA and HIDEKAZU SUZUKI
    Anticancer Research January 2025, 45 (1) 369-378; DOI: https://doi.org/10.21873/anticanres.17425
  • You have access
    Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell Carcinoma
    GAKU ISHIKAWA, KEITA TAMURA, YOSHIHIRO TSUCHIYA, SHUNSUKE WATANABE, TAKEMURA AYANA, SANO ASUKA, KYOHEI WATANABE, HIROMITSU WATANABE, YUTO MATSUSHITA, DAISUKE MOTOYAMA, ATSUSHI OTSUKA and TERUO INAMOTO
    Anticancer Research January 2025, 45 (1) 379-386; DOI: https://doi.org/10.21873/anticanres.17426
  • You have access
    Prediction and Monitoring of Adaptive Radiation Therapy Timing Using Two-dimensional X-ray Image-based Water Equivalent Thickness
    KOUTA HIROTAKI, SHUNSUKE MORIYA, KENTO TOMIZAWA, MASASHI WAKABAYASHI, ATSUSHI MOTEGI, MASASHI ITO and TAKEJI SAKAE
    Anticancer Research January 2025, 45 (1) 387-397; DOI: https://doi.org/10.21873/anticanres.17427
  • You have access
    Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
    YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU
    Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428

Corrigenda

  • Open Access
    Corrigenda
    Anticancer Research January 2025, 45 (1) 405; DOI: https://doi.org/10.21873/anticanres.17429
Back to top
PreviousNext

In this issue

Anticancer Research: 45 (1)
Anticancer Research
Vol. 45, Issue 1
January 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Eribulin Induction of Immunogenic Cell Death (ICD): Comparison With Other Cytotoxic Agents and Temporal Relationship of ICD Biomarkers
  • How to Predict Recurrence After Resection of Hepatocellular Carcinoma
  • Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases
  • Gene Expression Profiles in Ovarian Cancer Tissues as a Potential Tool to Predict Platinum-based Chemotherapy Resistance
  • Interaction of Vitamin D-BODIPY With Fat Cells and the Link to Obesity-associated Vitamin D Deficiency
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire